These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26900642)

  • 1. Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy.
    Kassai A; Muniyappa R; Levenson AE; Walter MF; Abel BS; Ring M; Taylor SI; Biddinger SB; Skarulis MC; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1790-7. PubMed ID: 26900642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL-associated apoCIII plays an independent role in predicting postprandial hypertriglyceridemia.
    Zhang T; Tang X; Mao L; Chen J; Kuang J; Guo X; Xu D; Peng D; Yu B
    Clin Biochem; 2020 May; 79():14-22. PubMed ID: 32045574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.
    Muniyappa R; Abel BS; Asthana A; Walter MF; Cochran EK; Remaley AT; Skarulis MC; Gorden P; Brown RJ
    J Clin Lipidol; 2017; 11(2):543-550. PubMed ID: 28502512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism.
    Luo M; Su X; Yi Y; Yang Y; Peng D
    Lipids Health Dis; 2018 Jul; 17(1):160. PubMed ID: 30021607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.
    Katzmann JL; Werner CM; Stojakovic T; März W; Scharnagl H; Laufs U
    Lipids Health Dis; 2020 May; 19(1):116. PubMed ID: 32473635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.
    Han Y; Qi R; Liu G
    Biochem Biophys Res Commun; 2015 Jul; 462(4):420-5. PubMed ID: 25969427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial and generalized lipodystrophy: comparison of baseline characteristics and response to metreleptin.
    Diker-Cohen T; Cochran E; Gorden P; Brown RJ
    J Clin Endocrinol Metab; 2015 May; 100(5):1802-10. PubMed ID: 25734254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin.
    Lightbourne M; Wolska A; Abel BS; Rother KI; Walter M; Kushchayeva Y; Auh S; Shamburek RD; Remaley AT; Muniyappa R; Brown RJ
    J Endocr Soc; 2021 Feb; 5(2):bvaa191. PubMed ID: 33442570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a hypertriglyceridemic transgenic miniature pig model expressing human apolipoprotein CIII.
    Wei J; Ouyang H; Wang Y; Pang D; Cong NX; Wang T; Leng B; Li D; Li X; Wu R; Ding Y; Gao F; Deng Y; Liu B; Li Z; Lai L; Feng H; Liu G; Deng X
    FEBS J; 2012 Jan; 279(1):91-9. PubMed ID: 22023023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index.
    Wu JH; Kao JT; Wen MS; Lo SK
    J Formos Med Assoc; 2000 May; 99(5):367-74. PubMed ID: 10870325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein CIII and diabetes. Is there a link?
    Christopoulou E; Tsimihodimos V; Filippatos T; Elisaf M
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3118. PubMed ID: 30557902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum.
    Wang Y; Song Z; Wagner JD; Pachuk C; Subramanian RR
    J Lipid Res; 2011 Jun; 52(6):1265-1271. PubMed ID: 21371998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ApoCIII: the next PCSK9?
    Bernelot Moens SJ; van Capelleveen JC; Stroes ES
    Curr Opin Lipidol; 2014 Dec; 25(6):418-22. PubMed ID: 25255477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.
    Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE
    Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
    Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma apoCIII Levels in Relation to Inflammatory Traits and Metabolic Syndrome in Patients not Treated with Lipid-lowering Drugs Undergoing Coronary Angiography.
    Wu NQ; Li S; Zhang Y; Zhu CG; Guo YL; Gao Y; Qing P; Sun J; Liu G; Dong Q; Li JJ
    Biomed Environ Sci; 2017 Jan; 30(1):1-9. PubMed ID: 28245894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein CIII links dyslipidemia with atherosclerosis.
    Kawakami A; Yoshida M
    J Atheroscler Thromb; 2009 Mar; 16(1):6-11. PubMed ID: 19262004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
    van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
    Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.